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Embracing sulﬁde and CO to understand nitric oxide biologyResearch in the ﬁeld of nitric oxide (NO) biology has come a
long way from its humble beginnings revolving around the identi-
ﬁcation of the ‘endothelium-dependent relaxing factor’ (EDRF) to
the ubiquitous cell messenger, modulator and regulator of cellular
activity it is recognized today. Those of us who had the good
fortune to witness the development of this ﬁeld of research over
the years will remember the moments where the cross-talk of
NO with other biomolecules became a central feature of the NO
signalling process. Some of you may even have had a similar
‘‘deja-vu’’ feeling as we experienced while listening to the other
individual’s lecture at one of those themed integrated physiology
meetings. At the occasion of one such meeting in Glasgow in
2010 the two of us could not help wondering why NO and sulﬁde
appeared so similar when viewed through the looking glass of
‘‘hypoxic tolerance’’. This Editorial serves to explain the Nitric
Oxide Society Board Members’ decision to expand the scope of
our ‘‘house journal’’ to include the biology and chemistry of two
other signalling molecules, a decision most of us feel is timely
and justiﬁed as the ﬁeld has evolved.
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Open access under CC BY-NC-ND license.NO was the ﬁrst of a new class of signalling molecules, followed
at 8–10 year intervals by carbon monoxide (CO) and hydrogen sul-
ﬁde (H2S) and now collectively known as ‘‘gasotransmitters’’.
Unfortunately, that term turned out to be somewhat of a misnomer
which continues to invite conceptual misunderstandings. While all
three substances are indeed gasses at STP, in cells they do not move
about and signal in the form of tiny gas puffs. When produced in
tissues and biological ﬂuids they are ‘solutes’ and may use sophis-
ticated transport mechanisms to cross cellular membranes. This
would seem to make it easier to target biological actions to speciﬁc
sites while avoiding production of waste, which is bioenergetically
costly to eliminate or recycle. Formation of the latter would seem
inevitable if NO was to reach its target simply by random diffusion.
All three substances have in common that they are very small,
interact with other biomolecules (in particular metals and hemes,
although this does not necessarily translate into a change in bio-
logical activity), were known as atmospheric pollutants and toxic
entities long before their endogenous production was established,
and that lower rates of formation can protect tissues from damage.
In the case of NO and CO this has been shown to result in either en-
zyme activation or inhibition. Although slow in the absence of cat-
alysts, NO and H2S also react with oxygen (O2) to form an array of
metabolites with distinct biological properties and chemical reac-
tivities. The availability of NO is dependent on the relative rates
of NO formation and trapping by oxygenated hemes, co-generated
reactive oxygen species and perhaps H2S. Thus, the formation of
secondary reactive nitrogen oxide species such as peroxynitrite
(ONOO), nitrogen dioxide (NO2), and dinitrogen trioxide (N2O3)
all depends on the relative ﬂux rates of generation of individual
reactants, nearby antioxidant enzyme expression/activity, and
even the presence of carbon dioxide/bicarbonate (CO2/HCO3). As
whether this was not complicated enough already, there is ample
cross-talk between many of these species at multiple levels,
including direct chemical interactions leading to formation of
new reaction products, reciprocal interaction at the functional le-
vel affecting production and metabolism of either signalling enti-
ties, and other modulatory processes due to post-translational
modiﬁcation of proteins involved in down-stream signalling.
It has been known for some time that NO can react with thiols to
form S-nitrosothiols. This editorial is neither the place to discuss the
various reactions that account for the formation of those products in
biology nor to get into trouble by citing the wrong papers/group that
made important contributions to this or that area ﬁrst, but one thing
seems to be clear: the post-translational modiﬁcation of critical pro-
tein sulfhydryl groups by S-nitrosation is becoming increasingly rec-
ognized as an important means of regulating cellular activity,
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lation of soluble guanylyl cyclase activity and inhibition of the mito-
chondrial respiratory chain is for its acute effects. While H2S may be
seen by some as ‘‘just another’’ transmitter, it also happens to be the
smallest reduced thiol with a unique chemical reactivity. So, no
wonder it cross-talks with NO at multiple levels. Thiolates are
among the most nucleophilic reactants in cells and heavily invested
in governing protein structure and function. It is perhaps not sur-
prising that thiol reactivity can be modiﬁed in many other ways,
including sulfhydryl oxidation, nitrosation, nitration, thiolation,
and guanylation. Add to this the possibility that multiple sulphur-
oxy species and polysulﬁdes may be formed that can react either
with NO directly or one of its metabolites, and it becomes obvious
why it can become challenging to keep track of what exactly is hap-
pening in biological systems at the molecular level.
At the beginning, everything looked relatively straigthforward:
H2S, formed by two enzymes of the trans-sulfuration pathway,
either inhibited complex IV of the respiratory chain, leading to cel-
lular ‘‘power failure’’, or elicited its biological effect through modiﬁ-
cation of KATP channel activity. Soon thereafter, however,
observations appeared in the literature that described either en-
hanced release or inhibition of NO, involvement of nitroxyl, sulfhy-
dration (formation of a mixed disulﬁde with SH, giving rise to
perthiols) and other ways of tweaking cellular activity levels. Recent
studies have even shown that H2S can be a substrate in the respira-
tory chain, donate electrons for ATP synthesis and protect mito-
chondrial integrity. Moreover, we now know of several other
pathways that can give rise to H2S, yet how exactly H2S exerts its
biological action has become far less clear. To be frank, in most cases
we don’t even know which molecular entity mediates its biological
effects. Since at physiological pH the majority of it is present in the
form of the hydrosulﬁde anion (HS-), it may well be that this pow-
erful nucleophile, and not its conjugate acid H2S, is the major carrier
of biological activity (which, if true, would probably disqualify it
from being a ‘‘gasotransmitter’’). To this end it is interesting to note
that polysulﬁdes are increasingly gaining attention as possible sig-
nalling entities in their own right – time will tell which sulfur spe-
cies accounts for the majority of the biological activity of ‘‘H2S’’.
NO research has greatly beneﬁtted from the early mechanistic
elucidation of its biosynthetic route, the identiﬁcation of the three
isoenzymes of the NO-synthase family, and the availability of speciﬁc
NOS inhibitors. The early years were characterized by the excitement
of identifying one system after another to be under tonic control of
NO. In the early days of NO research, it was often sufﬁcient to mon-
itor what happens following application of a NOS inhibitor to a given
biological system and demonstrate partial/full reversal of whatever
effect observed following NO replenishment by a NO-donor to pro-
duce a paper. In part this was possible because so many biological
processes are under control of NO, one way or another. Clearly, those
days are long gone, but the H2S ﬁeld never had the opportunity to use
a single enzyme inhibitor to probe for the involvement of H2S in a gi-
ven mechanism/cell signalling pathway, and many of the inhibitors
available are either not very potent or rather unspeciﬁc.
NO research has also beneﬁtted from a thorough systematic
assessment of its biological chemistry in the past two decades.
By comparison, the chemical biology of H2S (or maybe (poly)sul-
ﬁde?) is still in its infancy. Like many years before in the NO ﬁeld,
there is a lack of sufﬁciently sensitive and speciﬁc analysis tech-
niques around to reliably quantify the different sulfur species in
biological systems in order to get a proper handle on the signalling
process. That kinetics of release and consumption are important for
availability has been appreciated early on in the NO ﬁeld, but does
not seem to be common knowledge in the H2S ﬁeld. Several H2S
donors have been synthesized, but only few reports have appeared
that compared their biological effects with those of simple sulﬁde
salts. Several new probes for H2S have been developed recently,but no good scavengers have emerged yet. There is a lot to do,
and we are likely to witness a couple of surprises along the way.
By comparison, research in the ﬁeld of CO biology appears to be
more straightforward. For a start, CO is not redox active, which helps
simplifying matters. The biological activity of CO is largely domi-
nated by metal coordination chemistry (classic organometallic
chemistry with established model systems) and its production from
heme is subject to less complicated ﬁne-regulation of cofactor avail-
abilities etc. Yet, we may be up for a surprise in this area of research,
too, as new tools such as slow CO-releasing molecules (comparable
to NO-donors and H2S/sulﬁde donors in the other two ﬁelds) and
CO-sensitive probes are becoming available. While there are several
ways of inhibiting and upregulating heme oxygenase activity/
expression to the best of our knowledge no speciﬁc CO-scavengers
yet exist in our pharmacological tool box. Also, rumour has it that
this ﬁeld is in desperate search for an endogenous biological target
now as soluble guanylyl cyclase does not seem to be it.
Small molecule transmitters might be seen as lacking in selec-
tivity as larger molecules (such as hormones) owe their selectivity
largely to their three-dimensional structure. However, with NO
and CO nature has chosen two small molecules that, except when
required, are curiously unreactive. In particular NO is a radical, yet
an unusually unreactive one. By and large, NO only reacts with
other radicals and with metals, CO with metals, and H2S. . . well,
we have to wait and see.
While the NO ﬁeld has matured over the years, signiﬁcant chal-
lenges remain. Among other things, this relates to the chemistry
that governs its biological signalling, and this is where the cross-
talk between these three ‘‘gasses’’ comes into play. In order to fully
understand how NO elicits its many effects in a targeted fashion
we will need to untangle the rich chemical cross-talk between dif-
ferent molecular entities belonging to each of these pathways. To
make real progress in this ﬁeld now we require more detailed in-
sight into how the effects of NO depend on the two other systems
(and perhaps further ones to be discovered in the future), how to
therapeutically manipulate it for patient beneﬁt, improve stress
tolerance of plants, or whatever your particular area of research
may be. This is why the Editors of this journal have decided it
was time to broaden its scope to include sulﬁde and CO. As the sci-
ence evolves, so should we and our journal.
Thus, in addition to sending your best work on NO to this jour-
nal, from now on we wish to invite papers from the adjacent H2S
and CO ﬁelds to become the premier outlet for publication of re-
search on the chemistry and biology of NO, sulﬁde and CO. The
biology of these three messengers appears to be so deeply inter-
twined that it will be difﬁcult, if not impossible, to appreciate
how NO works without understanding how the other two operate.
Stay tuned, it starts happening in this volume with two reviews by
the groups of Jack Lancaster [1] and Chris Kevil [2].
In the ﬁrst article, Li and Lancaster take us through the perilous
and often misunderstood ﬁeld of sulﬁde chemistry. This article is a
must read for anyone entering (and many of us active in) this ﬁeld
as it provides practical guidelines with which to appreciate synthe-
sis and degradation of H2S as well as understand possible interac-
tions with other signaling molecules and interactions between H2S
and downstream effector (receptor?) mechanisms. The authors
point out that there is clearly much more to be learned about
sulﬁde chemistry and provide a number of interesting avenues
for future research. We also learn that the correct IUPAC nomencla-
ture for H2S is ‘‘sulfane’’, although it is difﬁcult to imagine this in
our lexicon in the foreseeable future. In the second article, Kolluru
et al. discuss the methods for analyzing H2S, and provide an over-
view of H2S physiology. They point out that many of the commonly
applied methods used to measure H2S in blood and tissues are
associated with substantial artifact and result in unrealistically
elevated concentrations. Although this has been pointed out before
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many active investigators and certainly cannot be overstated. The
authors also provide a good summary of many of the proposed
physiological systems in which H2S has been implicated and an
overview of sulﬁde’s interactions with other molecular species.
These two papers provide a practical framework for investigators
entering this ﬁeld as well as a timely reminder to those of us
who are already in it. Enjoy.
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